Alternative methods symposium
This article was originally published in The Rose Sheet
Executive SummaryUpdates on development of alternative methods to animal testing and toxicological evaluations of ingredients will be offered at May 26 symposium in Nice, France, event organizer Pôle PASS says. Symposium is intended to shed light on state of affairs in "race against the clock" before Seventh Amendment to the European Cosmetics Directive is implemented in 2009, banning the use of animal testing in cosmetics development. Research Institute for Fragrance Materials, European Association for the Validation of Alternative Methods (ECVAM) and the European Cosmetic, Toiletry and Perfumery Association (Colipa) will participate. RIFM's Senior Test Program Specialist Jon Lalko will speak on role of alternative methods in evaluating safety of fragrance ingredients and bring attendees up to speed on RIFM's development activities and discuss how alternative testing methods fit in with group's safety assessment programs...
You may also be interested in...
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.
In 2019, Mylan moved up to become the world’s leading generics, biosimilars and OTC player, according to Informa Pharma Intelligence’s latest global rankings. Sandoz has surpassed troubled Teva into second place but is set to surrender that position following the sale of its US solid-dose and dermatology business to India’s Aurobindo.